These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 17158541)

  • 1. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
    Mitra AP; Datar RH; Cote RJ
    J Clin Oncol; 2006 Dec; 24(35):5552-64. PubMed ID: 17158541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
    Wallerand H; Reiter RR; Ravaud A
    Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
    Wolff EM; Liang G; Jones PA
    Nat Clin Pract Urol; 2005 Oct; 2(10):502-10. PubMed ID: 16474624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of molecular markers for prognostication and outcome in invasive bladder cancer.
    Gakis G; Schwentner C; Todenhöfer T; Stenzl A
    BJU Int; 2012 Jul; 110(2):233-7. PubMed ID: 22233187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of tumor suppressor genes in bladder cancer.
    Cordon-Cardo C; Reuter VE
    Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for molecular expression profiling in bladder cancer.
    Mitra AP; Bartsch CC; Cote RJ
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):317-26. PubMed ID: 19997771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
    Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
    J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1996 May; 8(3):259-63. PubMed ID: 8794154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
    Knowles MA
    Carcinogenesis; 2006 Mar; 27(3):361-73. PubMed ID: 16352616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of invasive bladder cancers: histological and molecular markers.
    Liebert M; Seigne J
    Semin Urol Oncol; 1996 May; 14(2):62-72. PubMed ID: 8734733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic markers in muscle invasive bladder cancer.
    Tiguert R; Lessard A; So A; Fradet Y
    World J Urol; 2002 Aug; 20(3):190-5. PubMed ID: 12196903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium.
    Goebell PJ; Knowles MA
    Urol Oncol; 2010; 28(4):409-28. PubMed ID: 20610279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of urinary bladder cancer.
    Al Hussain TO; Akhtar M
    Adv Anat Pathol; 2013 Jan; 20(1):53-60. PubMed ID: 23232572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers in bladder cancer.
    Shariat SF; Karam JA; Lerner SP
    Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular alterations in bladder cancer.
    Cordon-Cardo C
    Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial tumorigenesis: a tale of divergent pathways.
    Wu XR
    Nat Rev Cancer; 2005 Sep; 5(9):713-25. PubMed ID: 16110317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.